Asthma Isn't What it Used to Be

Asthma care now leans harder on inhaled corticosteroids, antimuscarinics, and trigger control rather than rescue inhalers alone. In the ED, the crashing asthmatic is still an airflow and work-of-breathing problem where bronchodilators, steroids, magnesium, and selective noninvasive support all matter.

Updated Asthma Control Principles

• Inhaled steroid early role: Inhaled corticosteroids do more than reduce inflammation over hours; they also have an immediate synergistic effect with albuterol by upregulating beta-2 receptors.
• Frequent exacerbation signal: Two to three or more asthma flares a year leading to ED visits is a practical marker that controller therapy should be escalated, especially with inhaled corticosteroids.
• LAMA add-on option: Long-acting antimuscarinic antagonists are a useful alternative when LABAs are not tolerated and can be used alone or paired with inhaled corticosteroids.
• Allergic trigger mitigation: Environmental control still matters in allergic asthma: carpet removal, mattress covers, pet exclusion from the bedroom, and mold remediation can reduce ongoing airway irritation. We get into the counseling details in the episode.
• Antihistamine trial signal: A two-week trial of a non-sedating antihistamine can help selected patients with allergic asthma by reducing bronchial inflammation without adding sedation burden.

Emergency Management of Acute Asthma

• Bronchodilator delivery options: Albuterol remains the mainstay, and MDI plus spacer can substitute for nebulization; a rapid bronchodilator effect starts within minutes and lasts several hours.
• Ipratropium early pairing: Ipratropium bromide improves FEV1 by reducing bronchoconstriction and secretions, making it most useful early as part of initial combination bronchodilator therapy.
• Steroid route principle: Prednisone, methylprednisolone, and dexamethasone all fit acute care because oral and parenteral steroids have similar bioavailability; route should follow severity and practicality.
• Magnesium rescue bronchodilator: IV magnesium sulfate is a key adjunct for more severe exacerbations because it relaxes bronchial smooth muscle; the escalation approach is worth hearing in the chapter.
• Epinephrine severe asthma role: IM epinephrine 0.3-0.5 mg is a frontline move in life-threatening asthma when airflow is collapsing, with IV options reserved for selected monitored patients.
• BiPAP and ketamine bridge: Noninvasive ventilation can unload work of breathing and drive aerosol deeper, while subdissociative ketamine may improve tolerance and adds bronchodilatory benefit.

Crashing Asthmatic and Intubation

• Intubation as last resort: Endotracheal intubation in status asthmaticus is a salvage step because positive-pressure ventilation can worsen dynamic hyperinflation and hemodynamic collapse.
• Delayed sequence approach: A delayed sequence strategy using ketamine while maintaining noninvasive support can preserve oxygenation and buy time before committing to the tube.
• Large tube low rate: Post-intubation ventilation favors a large endotracheal tube, low respiratory rate, and prolonged expiratory time to limit air trapping. We walk through the setup on the show.
• Beta agonist receptor washout: Heavy beta-agonist exposure can functionally blunt response, which is one reason steroids remain essential early: they help restore receptor responsiveness.

References

1. Expert Panel Working Group of the National Heart, Lung, and Blood Institute (NHLBI) administered and coordinated National Asthma Education and Prevention Program Coordinating Committee (NAEPPCC), Cloutier MM, Baptist AP, et al. 2020 Focused Updates to the Asthma Management Guidelines: A Report from the National Asthma Education and Prevention Program Coordinating Committee Expert Panel Working Group. J Allergy Clin Immunol. 2020;146(6):1217-1270. PMID: 33280709
2. Bond KR, et al. Non-invasive ventilation use in status asthmaticus: 16 years of experience in a tertiary intensive care. Emerg Med Australas. 2018;30(2):187-192. PMID: 29131536
3. Miller A, et al. Noninvasive ventilation in life-threatening asthma: A case series. Can J Respir Ther. 2017;53(3):33-36. PMID: 30996631.
4. Smith D, et al. Intravenous epinephrine in life-threatening asthma. Ann Emerg Med. 2003;41(5):706-711. PMID: 12712039
5. Esmailian M, et al. The Effect of Low-Dose Ketamine in Treating Acute Asthma Attack; a Randomized Clinical Trial. Emerg (Tehran). 2018;6(1):e21. PMID: 30009223.